pipette
ESEspañol

Sidetrak: a de novo-designed miniprotein targets the kinesin-1 coiled-coil stalk to inhibit MAP7 binding and disrupt mitochondrial transport

J. A. Cross, S. A. Bristow, T. Babuji, D. Woolfson, M. P. Dodding

Preprint

In the authors' words

The coiled-coil domains of cytoskeletal motors contain regulatory surfaces that offer largely unexploited targets for manipulating intracellular transport. The microtubule-associated protein MAP7 promotes kinesin-1 motor activity, binding a coiled-coil surface that overlaps the TPR docking site (TDS), a regulatory interface involved in autoinhibition. Starting from an AlphaFold3 model of this relatively feature-poor surface, we used BoltzGen to design Sidetrak, a 36-amino acid miniprotein that binds kinesin-1 with nanomolar affinity. Binding requires the TDS and is abolished by mutation of the predicted Sidetrak interface, supporting the modelled local geometry of the targeted coiled-coil region. Sidetrak inhibits MAP7 binding, reduces MAP7-dependent kinesin-1 recruitment to microtubules in cells and causes perinuclear redistribution of mitochondria, a kinesin-1 cargo. Sidetrak binds all three kinesin-1 heavy-chain paralogues, and quantitative interaction proteomics revealed selective association with endogenous kinesin-1 complexes and associated cargo adaptors. These findings demonstrate selective disruption of a motor-MAP interaction by a de novo-designed protein and highlight regulatory coiled-coil surfaces as targets for manipulating intracellular transport. Beyond providing a means to manipulate intracellular transport, this work illustrates the potential of de novo protein design to test structural models of protein interfaces and probe endogenous protein networks to uncover underlying cellular mechanisms.

Main resultThe abstract does not state a limitation.

Appeared: Thursday, November 19. bioRxiv. Preprint, not yet peer-reviewed.

DOI: 10.64898/2026.11.16.767073